000 | 01923 a2200541 4500 | ||
---|---|---|---|
005 | 20250516233819.0 | ||
264 | 0 | _c20150810 | |
008 | 201508s 0 0 eng d | ||
022 | _a1460-2091 | ||
024 | 7 |
_a10.1093/jac/dku370 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCalin, Ruxandra | |
245 | 0 | 0 |
_aVery early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and Δ32 heterozygote HIV-1-infected patient was not associated with functional cure. _h[electronic resource] |
260 |
_bThe Journal of antimicrobial chemotherapy _cJan 2015 |
||
300 |
_a317-9 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xmethods |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aDNA, Viral _xblood |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 |
_aHIV Antibodies _xblood |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV-1 _ximmunology |
650 | 0 | 4 |
_aHLA-B Antigens _xgenetics |
650 | 0 | 4 | _aHeterozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlasma _xvirology |
650 | 0 | 4 |
_aRNA, Viral _xblood |
650 | 0 | 4 |
_aReceptors, CCR5 _xgenetics |
650 | 0 | 4 | _aSequence Deletion |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aViral Load |
700 | 1 | _aFourati, Slim | |
700 | 1 | _aSchneider, Luminita | |
700 | 1 | _aGautheret-Dejean, Agnes | |
700 | 1 | _aLambert-Niclot, Sidonie | |
700 | 1 | _aWirden, Marc | |
700 | 1 | _aCarcelain, Guislaine | |
700 | 1 | _aKatlama, Christine | |
700 | 1 | _aMarcelin, Anne-Geneviève | |
700 | 1 | _aTubiana, Roland | |
773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 70 _gno. 1 _gp. 317-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dku370 _zAvailable from publisher's website |
999 |
_c24206846 _d24206846 |